Child Anxiety Study at Columbia University

Child Anxiety Study at Columbia University Study IRB number: #2019-0642

We are researchers at Columbia University Medical Center/New York State Psychiatric Institute conducting a research study in which we offer evaluation and treatment for children and teenagers with anxiety disorders.

08/04/2020

Check out our website to learn more about our research and participate in our studies!

08/04/2020

The Levine Lab and the Youth Treatment and Evaluation of Anxiety and Mood Program of Columbia University Medical Center/New York State Psychiatric Institute is conducting a research study in which we offer free evaluation and treatment for anxiety disorders for children and adolescents ages 8-17. We are searching for biomarkers to determine predicted treatment response to sertraline (Zoloft).

In order to be eligible for this research study, your child must:
• Be 8 - 17 years old
• Speak/Read English
• Need treatment for anxiety
• Be able to swallow intact tablets
• Have not initiated psychotherapy within 8 weeks of screening
• Not be currently taking an SSRI medication

We are also recruiting healthy children and adolescents without anxiety. These participants would not take any medication as part of the study, but would still have a clinical evaluation.

In order to be eligible as a healthy control for this research study, your child must:
• Be 8-17 years old
• Speak/Read English
• Not be diagnosed with any psychiatric disorders
• Not have immediate family that has been diagnosed with anxiety or depression

Address

1051 Riverside Drive, Unit 78
New York, NY
10032

Telephone

+6467747331

Website

Alerts

Be the first to know and let us send you an email when Child Anxiety Study at Columbia University posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Child Anxiety Study at Columbia University:

Shortcuts

Featured

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category